Format

Send to

Choose Destination
J Surg Oncol. 2007 Sep 15;96(4):309-15.

Radio-guided surgery in neuroendocrine tumors.

Author information

1
Center for Cancer Care at Goshen Health System, Goshen, IN, USA.

Abstract

The majority of Neuroendocrine tumors (NET) express somatostatin (SS) receptors, and thus can be successfully targeted with radiolabeled SS analogs in vivo. Somatostatin receptor scintigraphy (SRS) with (111)In-DTPA Octreotide is the main imaging technique for evaluation of NETs. Radio-guided surgery for NETs, therefore, primarily utilizes (111)In-DTPA Octreotide tumor localization mechanism and kinetics. Somatostatin analog radiopharmacy continues to evolve to include the development of more selective and higher affinity analogs and PET tracers. These changes are expected to open new venues for radio-guided surgery technology.

PMID:
17726664
DOI:
10.1002/jso.20868
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center